SCHEMBL23861571

SCHEMBL23861571

Oc1cccc2c(O)c(C(c3ccccc3)(c3ccccc3)c3ccc4c(O)cccc4c3O)ccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 6/20 0.45
▸ HPGD P15428 5/20 0.45
▸ CYP1A2 P05177 3/20 0.45
▸ CYP2C9 P11712 3/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ IDO1 P14902 2/20 0.41
▸ THRB P10828 2/20 0.37
▸ ALOX15 P16050 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ RECQL P46063 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ APP P05067 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ SNCA P37840 1/20 0.36
▸ KCNJ11 Q14654 1/20 0.36
▸ LMNA P02545 3/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861573 0.81 THRB (0.47) HSD17B10HPGDCYP1A2CYP2C9CYP2D6
SCHEMBL18308670 0.81 IDO1 (0.54) HSD17B10HPGDCYP1A2CYP2C9CYP2D6
SCHEMBL9973585 0.79 ALDH1A1 (0.46) HSD17B10HPGDCYP1A2CYP2C9CYP2D6
SCHEMBL23861628 0.79 MAPT (0.55) HSD17B10HPGDCYP1A2CYP2C9CYP2D6
SCHEMBL23264379 0.76 CA2 (0.56) HSD17B10HPGDCYP1A2CYP2C9IDO1
SCHEMBL23861564 0.75 KCNJ11 (0.42) HSD17B10HPGDCYP1A2CYP2C9CYP2D6
SCHEMBL3478281 0.75 ALDH1A1 (0.46) HSD17B10HPGDCYP1A2CYP2C9CYP2D6
SCHEMBL11131095 0.75 ALDH1A1 (0.46) HSD17B10HPGDCYP1A2CYP2C9CYP2D6
SCHEMBL23861353 0.75 HPGD (0.39) HSD17B10HPGDCYP1A2CYP2C9CYP2D6
SCHEMBL30536501 0.75 ALDH1A1 (0.46) HSD17B10HPGDCYP1A2CYP2C9CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 HSD17B10 552/4885HPGD 1508/4885CYP1A2 2085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback